MCM
TNDM icon

Moore Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Moore Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-220,479
Closed -$2.68M – 826
2025
Q3 		$2.68M Buy
220,479
+160,753
+269% +$2.18M 0.04% 323
2025
Q2 		$1.11M Sell
59,726
-44,725
-43% -$886K 0.01% 368
2025
Q1 		$2M Buy
104,451
+83,453
+397% +$2.44M 0.04% 267
2024
Q4 		$756K Buy
+20,998
New +$710K 0.01% 400

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Moore Capital Management's TNDM Position: Q4 2025 in Review

Moore Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 220,479 shares — an estimated $2.68M sold.

Moore Capital Management first reported a position in TNDM in Q4 2024 and held it in 4 quarters. The position peaked at $2.68M in Q3 2025. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Moore Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Moore Capital Management sold 220,479 Tandem Diabetes Care shares in Q4 2025, an estimated $2.68M.
  • Moore Capital Management first reported a position in Tandem Diabetes Care in Q4 2024 and held it in 4 quarters.
  • Moore Capital Management's Tandem Diabetes Care position peaked at $2.68M in Q3 2025.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Moore Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.